In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
- 1 July 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 229 (3), 161-164
- https://doi.org/10.1016/s0304-3940(97)00442-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic PropertiesJournal of Medicinal Chemistry, 1997
- LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate ReceptorsNeuropharmacology, 1997
- A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampusNeuroscience Letters, 1996
- Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibodyNeuroscience Letters, 1996
- Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrusEuropean Journal of Pharmacology, 1995
- Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomesEuropean Journal of Pharmacology, 1995
- The metabotropic glutamate receptors: Structure and functionsNeuropharmacology, 1995
- Overview of chemical sampling techniquesJournal of Neuroscience Methods, 1993
- Metabotropic glutamate receptors in brain function and pathologyTrends in Pharmacological Sciences, 1993
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992